Praconase

DB05584InvestigationalProtein Based Therapies

Investigated for use/treatment in spinal cord injuries.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in spinal cord injuries.Curator reviewed
Also known as
EXOENZYME C3 TRANSFERASE (CLOSTRIDIUM BOTULINUM VARIANT VX-210) FUSION PROTEIN WITH TRANSPORT PEPTIDE (SYNTHETIC)
Code names
BA-210 · VX-210

Resolves to

Compound
UNIIB36V5S1RFJCAS1186547-12-5
Targets
P61586RHOA

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Praconase, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In